Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Distal Ischemic Stroke Treatment with Adjustable Low-profile Stentriever

    Stroke is a condition where the blood flow to the brain is blocked, potentially resulting in lack of oxygen, brain damage and loss of function ...

    View Details

  • An Observational Longitudinal Prospective Long-Term Registry of Patients With Hypophosphatasia

    This multinational, multicenter, observational, prospective, long-term registry is designed to collect data on epidemiology, hypophosphatasia (HPP) history, clinical course, symptoms (including systemic aspects of disease ...

    View Details

  • A Phase 1/1b Open-label Multicenter Study to Investigate the Safety Tolerability Pharmacokinetics and Antitumor Activity of KIN-2787 in Participants with BRAF and/or NRAS Mutation-positive Solid Tumors.

    You can participate in this study if you are diagnosed with stage 3 or stage 4 skin melanoma. The purpose of this study is to ...

    View Details

  • Mitral Valve Screening Survey (MVSS)

    Numerous transcatheter mitral valve interventions have emerged as a treatment option for patients with mitral valve disease. Development of transcatheter mitral valve repair (TMVr) and ...

    View Details

  • Long-Term Follow-Up Study of Patients with Spinal Muscular Atrophy Receiving Risdiplam Treatment

    This study will evaluate the long-term safety and effectiveness of risdiplam (Evrysdi?), prescribed on the basis of the U.S. Package Insert (USPI) and clinician ...

    View Details

  • I-SPY 2 TRIAL -Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis 2

    The I-SPY 2.2 study is a way to improve how we treat breast cancer. It uses a plan to test new treatments and find ...

    View Details

  • A Phase 1b/2 Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants with Advanced or Metastatic Colorectal Cancer.

    You can participate in this study if you are diagnosed with histologically or cytologically confirmed unresectable or metastatic adenocarcinoma of the colon or rectum. The ...

    View Details

  • Phase 2 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

    The objectives of this study are to evaluate the efficacy and safety of an oral medication, "ALXN2050", compared to placebo and establish an effective dose ...

    View Details